FREE CME/CE SATELLITE SYMPOSIUM
*This symposium is neither sponsored nor endorsed by the American Academy of Pediatrics
Identify AD based on the evaluation of clinical characteristics specific to infants, children, and adolescents
Examine the efficacy and safety of current non-pharmacological and pharmacological treatments for AD patients across the age spectrum
Define the rationale and mechanism of action for the use of new and emerging agents, including crisaborole, dupilumab, and oral JAK inhibitors in the management of AD
Develop individualized treatment plans for pediatric patients with AD based on the efficacy and safety of current and new agents, treatment recommendations, and patient and caregiver preferences
View AccreditationThis symposium is neither sponsored nor endorsed by the American Academy of Pediatrics